AMIPHARM
Latest round
- Series C
Last raised
- Feb 2025
Total raised
- $2.7M
Investors
- 2
About AMIPHARM
, Ltd, founded in 2005, operates from Seongnam, South Korea, and is involved in the production of injectable treatments. AMIPHARM specializes in the development of scientifically validated and safe injectable solutions for localized fat reduction, primarily focusing on their core product, AYP-101. This injectable treatment utilizes phosphatidylcholine to selectively induce apoptosis (cell death) and lipolysis (fat breakdown) within adipocytes, offering a novel mechanism for reducing localized fat deposits. The company aims to enhance the quality of life for individuals seeking aesthetic improvements without the pain associated with traditional fat reduction methods, such as liposuction or other invasive techniques.AMIPHARM generates revenue through the distribution of its flagship product, AYP-101, to healthcare providers and aesthetic clinics that offer fat reduction services. The business model involves direct sales to these medical establishments, allowing practitioners to utilize the product on patients seeking non-invasive fat reduction alternatives. The revenue model supports healthcare providers in delivering effective treatments while ensuring the company’s profitability, although specific pricing details for AYP-101 have not been disclosed.
Who invested in AMIPHARM
2 investors across 1 round
See all investors in AMIPHARM
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Feb 28, 2025
Amount
$2.7M
Investors
Questions about AMIPHARM
Who invested in AMIPHARM?
AMIPHARM has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AMIPHARM raised?
AMIPHARM has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did AMIPHARM last raise money?
AMIPHARM's most recent round on record is a Series C, in Feb 2025.
What does AMIPHARM do?
, Ltd, founded in 2005, operates from Seongnam, South Korea, and is involved in the production of injectable treatments.
Where is AMIPHARM headquartered?
AMIPHARM is headquartered in Seongnam, South Korea.
Which VCs invest in companies like AMIPHARM?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at AMIPHARM's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like AMIPHARM? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.